基因治疗的体外体验。 - Suppr

Gene therapy's out-of-body experience.

作者信息

Scott Christopher Thomas, DeFrancesco Laura

机构信息

Nature Biotechnology.

出版信息

Nat Biotechnol. 2016 Jun 9;34(6):600-7. doi: 10.1038/nbt.3592.

DOI:10.1038/nbt.3592

PMID:27281416

Abstract

摘要

相似文献

Gene therapy's out-of-body experience.

Nat Biotechnol. 2016 Jun 9;34(6):600-7. doi: 10.1038/nbt.3592.

Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.

Hum Gene Ther Clin Dev. 2016 Jun;27(2):57-61. doi: 10.1089/humc.2016.29010.ind. Epub 2016 Jun 6.

EMA greenlights second gene therapy.

Nat Rev Drug Discov. 2016 May 3;15(5):299. doi: 10.1038/nrd.2016.93.

ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization.

Mol Ther. 2016 Jun;24(6):1013-1014. doi: 10.1038/mt.2016.98.

Gene therapy for ADA-SCID, the first marketing approval of an gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.

EMBO Mol Med. 2017 Jun;9(6):737-740. doi: 10.15252/emmm.201707573.

Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency.

Curr Gene Ther. 2012 Feb 1;12(1):57-65. doi: 10.2174/156652312799789253.

A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow.

Hum Gene Ther Clin Dev. 2015 Dec;26(4):203-7. doi: 10.1089/humc.2015.29006.koh.

Promising Results with Ex Vivo Lentiviral HSPC Gene Therapy in ADA-SCID.

Am J Med Genet A. 2021 Aug;185(8):2291-2292. doi: 10.1002/ajmg.a.61688.

A Promising Option for ADA-SCID Patients.

Am J Med Genet A. 2021 Nov;185(11):3184-3185. doi: 10.1002/ajmg.a.61705.

Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.

Hum Gene Ther Clin Dev. 2017 Mar;28(1):17-27. doi: 10.1089/humc.2016.191.

引用本文的文献

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.

Int J Mol Sci. 2022 Feb 19;23(4):2331. doi: 10.3390/ijms23042331.

Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy.

Mol Ther Methods Clin Dev. 2021 Jul 21;23:51-67. doi: 10.1016/j.omtm.2021.07.003. eCollection 2021 Dec 10.

Massively-Parallelized, Deterministic Mechanoporation for Intracellular Delivery.

Nano Lett. 2020 Feb 12;20(2):860-867. doi: 10.1021/acs.nanolett.9b03175. Epub 2019 Oct 28.

Acid ceramidase deficiency: Farber disease and SMA-PME.

Orphanet J Rare Dis. 2018 Jul 20;13(1):121. doi: 10.1186/s13023-018-0845-z.

Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.

Mol Ther Methods Clin Dev. 2017 Dec 1;9:23-32. doi: 10.1016/j.omtm.2017.11.008. eCollection 2018 Jun 15.

Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.

Hum Gene Ther. 2017 Mar;28(3):271-285. doi: 10.1089/hum.2016.135. Epub 2016 Dec 29.

本文引用的文献

Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS.

Mol Ther Methods Clin Dev. 2016 Feb 24;3:16007. doi: 10.1038/mtm.2016.7. eCollection 2016.

Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease.

Nat Biotechnol. 2016 Apr;34(4):424-9. doi: 10.1038/nbt.3513. Epub 2016 Mar 7.

Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.

Nat Biotechnol. 2015 Dec;33(12):1256-1263. doi: 10.1038/nbt.3408. Epub 2015 Nov 9.

Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.

Sci Transl Med. 2015 Sep 30;7(307):307ra156. doi: 10.1126/scitranslmed.aac5530.

Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.

JAMA. 2015 Apr 21;313(15):1550-63. doi: 10.1001/jama.2015.3253.

Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.

Mol Ther Nucleic Acids. 2015 Apr 14;4:e236. doi: 10.1038/mtna.2015.10.

Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

Blood. 2015 Apr 23;125(17):2597-604. doi: 10.1182/blood-2014-12-615948. Epub 2015 Mar 2.

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

N Engl J Med. 2014 Oct 9;371(15):1407-17. doi: 10.1056/NEJMoa1404588.

Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases.

Stem Cells Transl Med. 2014 May;3(5):636-42. doi: 10.5966/sctm.2013-0206. Epub 2014 Mar 28.

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Sci Transl Med. 2014 Mar 12;6(227):227ra33. doi: 10.1126/scitranslmed.3007280.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Gene therapy's out-of-body experience.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献